145 related articles for article (PubMed ID: 36861798)
21. Circular RNA circ-ZEB1 acts as an oncogene in triple negative breast cancer via sponging miR-448.
Pei X; Zhang Y; Wang X; Xue B; Sun M; Li H
Int J Biochem Cell Biol; 2020 Sep; 126():105798. PubMed ID: 32629026
[TBL] [Abstract][Full Text] [Related]
22. Silence of α1-Antitrypsin Inhibits Migration and Proliferation of Triple Negative Breast Cancer Cells.
Zhao Z; Ma J; Mao Y; Dong L; Li S; Zhang Y
Med Sci Monit; 2018 Sep; 24():6851-6860. PubMed ID: 30260937
[TBL] [Abstract][Full Text] [Related]
23. MiR-92b inhibited cells EMT by targeting Gabra3 and predicted prognosis of triple negative breast cancer patients.
Li YY; Zheng XH; Deng AP; Wang Y; Liu J; Zhou Q; Cheng GY; Jiang Q
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10433-10442. PubMed ID: 31841197
[TBL] [Abstract][Full Text] [Related]
24. MiR-940 Inhibited Cell Growth and Migration in Triple-Negative Breast Cancer.
Hou L; Chen M; Yang H; Xing T; Li J; Li G; Zhang L; Deng S; Hu J; Zhao X; Jiang J
Med Sci Monit; 2016 Oct; 22():3666-3672. PubMed ID: 27731867
[TBL] [Abstract][Full Text] [Related]
25. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.
Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W
BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392
[TBL] [Abstract][Full Text] [Related]
26. Aurora-A/ERK1/2/mTOR axis promotes tumor progression in triple-negative breast cancer and dual-targeting Aurora-A/mTOR shows synthetic lethality.
Zhang W; Xia D; Li Z; Zhou T; Chen T; Wu Z; Zhou W; Li Z; Li L; Xu J
Cell Death Dis; 2019 Aug; 10(8):606. PubMed ID: 31406104
[TBL] [Abstract][Full Text] [Related]
27. Bisdemethoxycurcumin Promotes Apoptosis and Inhibits the Epithelial-Mesenchymal Transition through the Inhibition of the G-Protein-Coupled Receptor 161/Mammalian Target of Rapamycin Signaling Pathway in Triple Negative Breast Cancer Cells.
Chou CH; Wang HK; Lin YC; Tsai DH; Lu MT; Ho CT; Hseu YC; Yang HL; Way TD
J Agric Food Chem; 2021 Dec; 69(48):14557-14567. PubMed ID: 34813306
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of miR‑214 attenuates the migration and invasion of triple‑negative breast cancer cells.
Zhang Y; Zhao Z; Li S; Dong L; Li Y; Mao Y; Liang Y; Tao Y; Ma J
Mol Med Rep; 2019 May; 19(5):4035-4042. PubMed ID: 30942417
[TBL] [Abstract][Full Text] [Related]
29. The PI3K/mTOR dual inhibitor NVP-BEZ235 stimulates mutant p53 degradation to exert anti-tumor effects on triple-negative breast cancer cells.
Cai J; Xia J; Zou J; Wang Q; Ma Q; Sun R; Liao H; Xu L; Wang D; Guo X
FEBS Open Bio; 2020 Apr; 10(4):535-545. PubMed ID: 32027103
[TBL] [Abstract][Full Text] [Related]
30. MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.
Chen H; Pan H; Qian Y; Zhou W; Liu X
Mol Cancer; 2018 Jan; 17(1):4. PubMed ID: 29310680
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-200b targets protein kinase Cα and suppresses triple-negative breast cancer metastasis.
Humphries B; Wang Z; Oom AL; Fisher T; Tan D; Cui Y; Jiang Y; Yang C
Carcinogenesis; 2014 Oct; 35(10):2254-63. PubMed ID: 24925028
[TBL] [Abstract][Full Text] [Related]
32. Curcumin inhibits proteasome activity in triple-negative breast cancer cells through regulating p300/miR-142-3p/PSMB5 axis.
Liu L; Fu Y; Zheng Y; Ma M; Wang C
Phytomedicine; 2020 Nov; 78():153312. PubMed ID: 32866906
[TBL] [Abstract][Full Text] [Related]
33. MiR-15/16 complex targets p70S6 kinase 1 and controls cell proliferation in MDA-MB-231 breast cancer cells.
Janaki Ramaiah M; Lavanya A; Honarpisheh M; Zarea M; Bhadra U; Bhadra MP
Gene; 2014 Dec; 552(2):255-64. PubMed ID: 25261849
[TBL] [Abstract][Full Text] [Related]
34. Circ_0062558 promotes growth, migration, and glutamine metabolism in triple-negative breast cancer by targeting the miR-876-3p/SLC1A5 axis.
Yuan M; Zhang J; He Y; Yi G; Rong L; Zheng L; Zhan T; Zhou C
Arch Gynecol Obstet; 2022 Nov; 306(5):1643-1655. PubMed ID: 35284960
[TBL] [Abstract][Full Text] [Related]
35. LncRNA-HAGLR motivates triple negative breast cancer progression by regulation of WNT2 via sponging miR-335-3p.
Jin L; Luo C; Wu X; Li M; Wu S; Feng Y
Aging (Albany NY); 2021 Aug; 13(15):19306-19316. PubMed ID: 34375306
[TBL] [Abstract][Full Text] [Related]
36. miR-374a-5p promotes tumor progression by targeting ARRB1 in triple negative breast cancer.
Son D; Kim Y; Lim S; Kang HG; Kim DH; Park JW; Cheong W; Kong HK; Han W; Park WY; Chun KH; Park JH
Cancer Lett; 2019 Jul; 454():224-233. PubMed ID: 31004703
[TBL] [Abstract][Full Text] [Related]
37. LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p.
Wang L; Luan T; Zhou S; Lin J; Yang Y; Liu W; Tong X; Jiang W
Cancer Med; 2019 Aug; 8(9):4389-4403. PubMed ID: 31215169
[TBL] [Abstract][Full Text] [Related]
38. miR-720 is a downstream target of an ADAM8-induced ERK signaling cascade that promotes the migratory and invasive phenotype of triple-negative breast cancer cells.
Das SG; Romagnoli M; Mineva ND; Barillé-Nion S; Jézéquel P; Campone M; Sonenshein GE
Breast Cancer Res; 2016 Apr; 18(1):40. PubMed ID: 27039296
[TBL] [Abstract][Full Text] [Related]
39. MiR-99a antitumor activity in human breast cancer cells through targeting of mTOR expression.
Hu Y; Zhu Q; Tang L
PLoS One; 2014; 9(3):e92099. PubMed ID: 24637915
[TBL] [Abstract][Full Text] [Related]
40. MiR-890 inhibits proliferation and invasion and induces apoptosis in triple-negative breast cancer cells by targeting CD147.
Wang C; Xu C; Niu R; Hu G; Gu Z; Zhuang Z
BMC Cancer; 2019 Jun; 19(1):577. PubMed ID: 31196010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
